Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Proost

Showing results (161-170 of 244) with videos related to

Pageof 25
Sort By:
Frontiers in Immunology|January 31, 2018
Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in MiceThiago Henrique Caldeira de Oliveira, Pedro Elias Marques, Fariba Poosti, et al.
The FEBS Journal|April 13, 2011
Expression analysis of the nucleocytoplasmic lectin 'Orysata' from rice in Pichia pastorisBassam Al Atalah, Elke Fouquaert, Dieter Vanderschaeghe, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 31, 2017
Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer" [J. Control. Release 239 (2016) 39-48]Barbara Grünwald, Jennifer Vandooren, Erica Locatelli, et al.
Frontiers in Immunology|February 28, 2022
Method Matters: Effect of Purification Technology on Neutrophil Phenotype and FunctionMarfa Blanter, Seppe Cambier, Mirre De Bondt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2016
Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancerBarbara Grünwald, Jennifer Vandooren, Erica Locatelli, et al.
Infection and Immunity|April 2, 2014
Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalisEva A V Moelants, Gitte Loozen, Anneleen Mortier, et al.
Arthritis Research & Therapy|July 19, 2006
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathiesPaul Proost, Sofie Struyf, Tamara Loos, et al.
Molecular Cancer Research : MCR|March 11, 2010
The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivoJo Vandercappellen, Sandra Liekens, Annelies Bronckaers, et al.
Allergy|August 11, 2025
An Inflammation-Associated Control Mechanism of Allergy by Proteolysis of IgEEstefania Ugarte-Berzal, Erik Martens, Rafaela Vaz Sousa Pereira, et al.
The Biochemical Journal|February 3, 2007
TLXI, a novel type of xylanase inhibitor from wheat (Triticum aestivum) belonging to the thaumatin familyEllen Fierens, Sigrid Rombouts, Kurt Gebruers, et al.
Pageof 25

Showing results (161-170 of 244) with videos related to

Sort By:
Pageof 25
Frontiers in Immunology|January 31, 2018
Intravital Microscopic Evaluation of the Effects of a CXCR2 Antagonist in a Model of Liver Ischemia Reperfusion Injury in MiceThiago Henrique Caldeira de Oliveira, Pedro Elias Marques, Fariba Poosti, et al.
The FEBS Journal|April 13, 2011
Expression analysis of the nucleocytoplasmic lectin 'Orysata' from rice in Pichia pastorisBassam Al Atalah, Elke Fouquaert, Dieter Vanderschaeghe, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 31, 2017
Corrigendum to "Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancer" [J. Control. Release 239 (2016) 39-48]Barbara Grünwald, Jennifer Vandooren, Erica Locatelli, et al.
Frontiers in Immunology|February 28, 2022
Method Matters: Effect of Purification Technology on Neutrophil Phenotype and FunctionMarfa Blanter, Seppe Cambier, Mirre De Bondt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|August 23, 2016
Matrix metalloproteinase-9 (MMP-9) as an activator of nanosystems for targeted drug delivery in pancreatic cancerBarbara Grünwald, Jennifer Vandooren, Erica Locatelli, et al.
Infection and Immunity|April 2, 2014
Citrullination and proteolytic processing of chemokines by Porphyromonas gingivalisEva A V Moelants, Gitte Loozen, Anneleen Mortier, et al.
Arthritis Research & Therapy|July 19, 2006
Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathiesPaul Proost, Sofie Struyf, Tamara Loos, et al.
Molecular Cancer Research : MCR|March 11, 2010
The COOH-terminal peptide of platelet factor-4 variant (CXCL4L1/PF-4var47-70) strongly inhibits angiogenesis and suppresses B16 melanoma growth in vivoJo Vandercappellen, Sandra Liekens, Annelies Bronckaers, et al.
Allergy|August 11, 2025
An Inflammation-Associated Control Mechanism of Allergy by Proteolysis of IgEEstefania Ugarte-Berzal, Erik Martens, Rafaela Vaz Sousa Pereira, et al.
The Biochemical Journal|February 3, 2007
TLXI, a novel type of xylanase inhibitor from wheat (Triticum aestivum) belonging to the thaumatin familyEllen Fierens, Sigrid Rombouts, Kurt Gebruers, et al.
Pageof 25